MEK inhibitors for the treatment of NRAS mutant melanoma
Saro Sarkisian,1 Diwakar Davar2 1Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USA; 2Division of Hematology-Oncology, Hillman Cancer Center and University of Pittsburgh, Pittsburgh, PA, USA Abstract: Melanoma is increasing rapidly in incidence and prevalence, esp...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2018-08-01
|
| Col·lecció: | Drug Design, Development and Therapy |
| Matèries: | |
| Accés en línia: | https://www.dovepress.com/mek-inhibitors-for-the-treatment-of-nras-mutant-melanoma-peer-reviewed-article-DDDT |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|